|
Name |
epipyrone A
|
Molecular Formula | C34H44O10 | |
IUPAC Name* |
2-(2,4-dimethylhexylidene)-14-[4-hydroxy-6-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]pyran-2-yl]-4-methyltetradeca-3,5,7,9,11,13-hexaenoicacid
|
|
SMILES |
CCC(C)CC(C)C=C(C=C(C)C=CC=CC=CC=CC=Cc1cc(O)c(C2OC(CO)C(O)C(O)C2O)c(=O)o1)C(=O)O
|
|
InChI |
InChI=1S/C34H44O10/c1-5-21(2)16-23(4)18-24(33(40)41)17-22(3)14-12-10-8-6-7-9-11-13-15-25-19-26(36)28(34(42)43-25)32-31(39)30(38)29(37)27(20-35)44-32/h6-15,17-19,21,23,27,29-32,35-39H,5,16,20H2,1-4H3,(H,40,41)/b7-6+,10-8+,11-9+,14-12+,15-13+,22-17+,24-18-/t21-,23-,27?,29?,30?,31?,32?/m0/s1
|
|
InChIKey |
YQULWNMZEPTDEC-YYCVHFITSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 612.72 | ALogp: | 4.1 |
HBD: | 6 | HBA: | 9 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 177.9 | Aromatic Rings: | 2 |
Heavy Atoms: | 44 | QED Weighted: | 0.127 |
Caco-2 Permeability: | -5.683 | MDCK Permeability: | 0.00001300 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.955 |
Human Intestinal Absorption (HIA): | 0.99 | 20% Bioavailability (F20%): | 0.014 |
30% Bioavailability (F30%): | 0.711 |
Blood-Brain-Barrier Penetration (BBB): | 0.14 | Plasma Protein Binding (PPB): | 91.13% |
Volume Distribution (VD): | 0.837 | Fu: | 5.03% |
CYP1A2-inhibitor: | 0.046 | CYP1A2-substrate: | 0.04 |
CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.061 |
CYP2C9-inhibitor: | 0.042 | CYP2C9-substrate: | 0.903 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.347 |
CYP3A4-inhibitor: | 0.006 | CYP3A4-substrate: | 0.081 |
Clearance (CL): | 0.261 | Half-life (T1/2): | 0.741 |
hERG Blockers: | 0.366 | Human Hepatotoxicity (H-HT): | 0.755 |
Drug-inuced Liver Injury (DILI): | 0.19 | AMES Toxicity: | 0.68 |
Rat Oral Acute Toxicity: | 0.557 | Maximum Recommended Daily Dose: | 0.981 |
Skin Sensitization: | 0.959 | Carcinogencity: | 0.169 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.636 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
D0FG6M | 0.241 | ||||||
D01TNW | 0.238 | ||||||
D02HYK | 0.227 | ||||||
D02VCJ | 0.223 | ||||||
D0D0SH | 0.219 | ||||||
D05ZYM | 0.214 | ||||||
D03JSJ | 0.213 | ||||||
D0S7DV | 0.212 | ||||||
D08DFX | 0.211 | ||||||
D06ALD | 0.209 |